Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

With more than 71 million people chronically infected, hepatitis C virus (HCV) is one of the leading causes of liver disease and hepatocellular carcinoma. While efficient antiviral therapies have entered clinical standard of care, the development of a protective vaccine is still elusive. Recent stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrensch, Florian, Crouchet, Emilie, Ligat, Gaetan, Zeisel, Mirjam B., Keck, Zhen-Yong, Foung, Steven K. H., Schuster, Catherine, Baumert, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021501/
https://www.ncbi.nlm.nih.gov/pubmed/29977246
http://dx.doi.org/10.3389/fimmu.2018.01436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021501/
https://www.ncbi.nlm.nih.gov/pubmed/29977246
http://dx.doi.org/10.3389/fimmu.2018.01436

Ejemplares similares